AVFIX-CV is a combination of Cefixime, a third-generation cephalosporin antibiotic, and Potassium Clavulanate, a β-lactamase inhibitor. This synergistic formulation enhances the efficacy of Cefixime by overcoming bacterial resistance caused by β-lactamase-producing organisms, offering powerful and extended coverage against tough bacterial infections.

Key Benefits:

• Combats resistant bacterial infections with dual-action synergy
• Broad-spectrum efficacy against gram-positive and gram-negative bacteria
• Effective for respiratory, urinary, and ENT infections
• Improved clinical outcomes in recurrent and chronic infections
• Convenient once or twice daily oral dosing

Indications:

• Acute sinusitis and tonsillitis
• Community-acquired pneumonia and bronchitis
• Otitis media (ear infections)
• Uncomplicated urinary tract infections
• Skin and soft tissue infections